Cargando…

Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression

PURPOSE: Loss of AT-rich DNA-interacting domain 1A (ARID1A) has been identified as a driving mutation of ovarian clear cell carcinoma (O-CCC), a triple-negative ovarian cancer that is intermediary between serous and endometrioid subtypes, in regards to molecular and clinical behaviors. However, abou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Jae Yoon, Han, Hyun Ho, Kim, Young Tae, Lee, Joo Hyun, Kim, Baek Gil, Kang, Suki, Cho, Nam Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122653/ https://www.ncbi.nlm.nih.gov/pubmed/27873496 http://dx.doi.org/10.3349/ymj.2017.58.1.59

Ejemplares similares

Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche
por: Han, Hyun Ho, et al.
Publicado: (2016)

Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma
por: Jung, Un Suk, et al.
Publicado: (2020)

Estrogen Receptor Status Predicts Late-Onset Skeletal Recurrence in Breast Cancer Patients
por: Han, Hyun Ho, et al.
Publicado: (2016)

Targeted sequencing with enrichment PCR: a novel diagnostic method for the detection of EGFR mutations
por: Kang, Suki, et al.
Publicado: (2015)

Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targets
por: Kim, Baek Gil, et al.
Publicado: (2016)

Compression-induced expression of glycolysis genes in CAFs correlates with EMT and angiogenesis gene expression in breast cancer
por: Kim, Baek Gil, et al.
Publicado: (2019)

Mechanical compression induces VEGFA overexpression in breast cancer via DNMT3A-dependent miR-9 downregulation
por: Kim, Baek Gil, et al.
Publicado: (2017)

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
por: Takahashi, Kazuaki, et al.
Publicado: (2021)

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
por: Sato, Emi, et al.
Publicado: (2018)

c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
por: Kim, Ha-Jeong, et al.
Publicado: (2016)

Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
por: Maeda, Daichi, et al.
Publicado: (2010)

Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma
por: Shin, Ha‐Yeon, et al.
Publicado: (2021)

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
por: Berns, Katrien, et al.
Publicado: (2018)

Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling
por: Kim, Baek Gil, et al.
Publicado: (2012)

Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study
por: Kim, Hee Seung, et al.
Publicado: (2016)

Clear cell odontogenic carcinoma mimicking a cystic lesion: a case of misdiagnosis
por: Kim, Minkyu, et al.
Publicado: (2014)

CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
por: Kawahara, Naoki, et al.
Publicado: (2021)

Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
por: Yano, Mitsutake, et al.
Publicado: (2019)

SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: A case report
por: Wagner, Samantha Kay, et al.
Publicado: (2023)

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019)

An atypical case of rare salivary malignancy, hyalinizing clear cell carcinoma
por: Kim, Dong Wook, et al.
Publicado: (2013)

Genetic analysis of ovarian microcystic stromal tumor
por: Lee, Jae Hoon, et al.
Publicado: (2016)

Difference of the Nuclear Green Light Intensity between Papillary Carcinoma Cells Showing Clear Nuclei and Non-neoplastic Follicular Epithelia in Papillary Thyroid Carcinoma
por: Lee, Hyekyung, et al.
Publicado: (2016)

Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma
por: Kwon, Byung Su, et al.
Publicado: (2018)

Significance of Intratumoral Fibrosis in Clear Cell Renal Cell Carcinoma
por: Joung, Jae Won, et al.
Publicado: (2018)

Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational Signatures
por: Oliveira, Douglas V. N. P., et al.
Publicado: (2021)

An Ovarian Steroid Cell Tumor Causing Virilization and Massive Ascites
por: Kim, Young Tae, et al.
Publicado: (2007)

Clinical Significance of Microsatellite Instability in Sporadic Epithelial Ovarian Tumors
por: Yoon, Bo-Sung, et al.
Publicado: (2008)

The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional Level
por: Goldman, Aaron R., et al.
Publicado: (2016)

Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
por: Ge, Huijuan, et al.
Publicado: (2021)

Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea
por: Kim, Se Ik, et al.
Publicado: (2022)

Mutational Analysis of KRAS, BRAF, and TP53 Genes of Ovarian Serous Carcinomas in Korean Women
por: Cho, Yun-Hyun, et al.
Publicado: (2009)

Mandibular clear cell odontogenic carcinoma
por: Kwon, Ik Jae, et al.
Publicado: (2015)

Clear cell papillary renal cell carcinoma: A case report and review of the literature
por: Kim, Sung Han, et al.
Publicado: (2018)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

Clinicopathologic characteristics of ovarian clear cell carcinoma in the background of endometrioma: a surveillance strategy for an early detection of malignant transformation in patients with asymptomatic endometrioma
por: Son, Joo-Hyuk, et al.
Publicado: (2019)

Targeted Inhibition of FAK, PYK2 and BCL-XL Synergistically Enhances Apoptosis in Ovarian Clear Cell Carcinoma Cell Lines
por: Yoon, Heejei, et al.
Publicado: (2014)

Effects of a continuous lateral turning device on pressure relief
por: Do, Nam Ho, et al.
Publicado: (2016)

GLS1 is a Protective Factor in Patients with Ovarian Clear Cell Carcinoma and its Expression Does Not Correlate with ARID1A-mutated Tumors
por: Clemente, Valentino, et al.
Publicado: (2022)

Endometrial Epithelial ARID1A Is Required for Uterine Immune Homeostasis during Early Pregnancy
por: Marquardt, Ryan M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g0l037eo3colsuqkeergmudemg